key: cord-0964140-d5vj3m7y authors: Yaghoubi, Neda; Youssefi, Masoud; Jabbari Azad, Farahzad; Farzad, Faramarz; Yavari, Zahra; Zahedi Avval, Farnaz title: Total antioxidant capacity as a marker of severity of COVID‐19 infection: Possible prognostic and therapeutic clinical application date: 2021-12-11 journal: J Med Virol DOI: 10.1002/jmv.27500 sha: 238ac55d34c484b6fcce07d0730e528a75f6f1dc doc_id: 964140 cord_uid: d5vj3m7y The pathogenesis of SARS‐CoV‐2 infection, causative pathogen of the known COVID‐19 pandemic is not well clarified. In this regard oxidative stress is one of the topics that need to be investigated. Therefore, the present research was performed to explore the relationship between the oxidant/antioxidant system and COVID‐19 exacerbation. Sera were collected from 120 patients with COVID‐19 infection and 60 healthy volunteers as the control group. The patient group consisted of 60 cases with mild disease and 60 severely ill patients. Serum levels of total antioxidant capacity (TAC) and nitric oxide (NO) as well as serum activities of the two main antioxidant defense enzymes, superoxide dismutase (SOD) and catalase (CAT), were measured. TAC levels were considerably lower in patients compared with healthy individuals (p < 0.05) and also between patients with mild and severe diseases (p < 0.05). A rather decreasing trend was also found in NO concentration as well as SOD and CAT activity, though, the observed differences were not statistically significant (p > 0.05). These findings suggest that COVID‐19 patients may be susceptible to depleted total antioxidant capacity. Moreover, showing such variations in blood samples of infected individuals could be considered as a predictive marker of COVID‐19 severity. between oxidant production and antioxidant protective responses that may be induced during natural metabolic processes or pathologic conditions. 8 Respiratory viral infections in general, cause the imbalance of the oxidant antioxidant system by overproduction of reactive oxygen or nitrogen species (ROS or RNS) and particularly superoxide ions. 9 Moreover, they may disturb the antioxidant defense potential against SARS-CoV-2 infection by a direct effect on the antioxidant molecules and enzymes or indirect influences such as suppressing the nuclear factor (erythroid-derived 2)-like 2 (NRF2) related defense 10 or activation of nuclear factor κB (NF-κB)-toll-like receptor (TLR) signaling pathways. 11 Similarly, SARS-CoV-2 binding to the angiotensin-converting enzyme-2 (ACE2) receptor helps the virus enter cells, however, leads to the subsequent reduction of the bioavailability of ACE2. 12 On the other side, the newly formed product, angiotensin II (Ang II), can interact with angiotensin type 1 (AT1R) and regulate the activation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) thereby ROS formation (superoxide radical anion (O 2 •− ) and hydrogen peroxide (H 2 O 2 ). 12 Another possible mechanism of oxidative stress during COVID infection is mediated by iron release into the bloodstream. 12 Indeed, SARS-CoV-2 may attack red blood cells (RBCs), lyze them, disturb oxygenation, and cause refractory hypoxemia as well as produce free Fe (III) ions that in turn can promote Fenton and Haber-Weiss reactions to induce oxidative stress. 12, 13 Any imbalance between generation and scavenging of ROS, can impair viral-specific innate immune responses, and activate compensatory responses through the redox-sensitive transcription factor NF-κB that is by far less specific against SARS-COV-II. 14 Furthermore, oxidation of proteins, lipids, and DNA by excessive ROS and necrosis of virus-infected cells may produce disease-associated molecular patterns sensed by adaptive immune cells. 15 Overall, diversion of antiviral innate immunity under oxidative conditions triggers pathological inflammation and lung injury by overproduction of proinflammatory cytokines and chemokines such as TNF-α, IL-6, IL-8, MCP1, and MIP1-α that unleash a cytokine storm and also exacerbate ROS production by activating NOX. [16] [17] [18] [19] Moreover, oxidative stress may cause hyporesponsiveness of T lymphocytes via oxidation of important regulatory proteins in T cells. 20 In this scenario, the antioxidant defense system may be of great value to reduce COVID-19 severity. Human antioxidants contain two main parts; nonenzymatic molecules such as glutathione, vitamins A, C, and E), and enzymatic systems like superoxide dismutase (SOD) and catalase (CAT). 21 The existing body of research on SOD suggests that it is the most powerful antioxidant enzyme and plays a key role in proper respiratory function. 22 In the same way, serum concentrations of NO (in μmol/ml) were measured by detecting nitrate and nitrite levels that can produce a pink azo product from a chromogenic agent. To calculate the nitrate amount, endogenous nitrite should be subtracted from the total nitrite levels according to the kit protocol. All analyses were carried out using Statistical Package for the The 3 | RESULTS Totally 180 participants were enrolled in this study, 60 healthy controls and 120 patients with COVID-19 disease including 60 critically ill patients and 60 outpatients with mild symptoms of infection. As shown in Table 1 , the study population consisted of 99 males (55%) and 81 females (45%) aged from 20 to 60 years. Four out of 60 severe cases died during the study process. Oxidative stress markers were categorized into oxidant (NO) and antioxidant indicators (TAC, SOD, and CAT). As indicated in Table 2 , TAC levels in patients with severe disease (0.06 ± 0.02, μM/L) was considerably lower than patients with mild symptoms (0.14 ± 0.03, μM/L) and healthy subjects (0.28 ± 0.11 μM/L) (p < 0.001). In the same way, a decreasing pattern in NO concentration and antioxidant enzyme activities were observed among the patient groups although it was not statistically significant (Figures 1-4 ). The COVID-19 pandemic has altered the global normal pace of life. 26 Serious health threats and remarkable morbidity and mortality rates of SARS-COV-II have inspired many researchers of various backgrounds to take quick actions to investigate possible guards against this world health problem. 27 Note: The p value compares severe disease, healthy controls, and mild disease groups. Statistical significances (ANOVA and Kruskal-Wallis test) were only seen in the case of TAC among the three studied groups. Abbreviations: CAT, catalase; NO, nitric oxide; SOD, superoxide dismutase; TAC, total antioxidant capacity. F I G U R E 1 No concentration among the three studied groups. ANOVA-test was used to determine the differences, indicated by asterisks. The values show insignificant differences between control (N = 60) and patients with severe disease (N = 60), (p > 0.05), control and patients with mild disease (N = 60) (p > 0.05), and between two groups of COVID positive patients (p > 0.05) F I G U R E 2 TAC concentration among the three studied groups. Kruskal-Wallis test was used to determine the differences, indicated by asterisks. The values show significant differences between control (N = 60) and severely-ill patients (N = 60) (****p = 0.0001), control and asymptomatic patients (N = 60) (****p = 0.0001), and between two groups of COVID positive patients (****p = 0.0001). TAC, total antioxidant capacity The difference in TAC levels over various groups of this study could be attributed to high ROS production, acute inflammatory condition and infiltration of inflammatory cells into the different organs, multiorgan involvement, and declined oxygen saturation. 14 A significant decrease in TAC levels was observed in patients, which could explain in part the pathogenesis of the infection and may be used for diagnostic, prognostic, and therapeutic purposes. This study was supported by a grant from Mashhad University of medical sciences (Grant No.: 990636). We thank all staff at the special COVID-19 ward for their kind assistance. The authors declare that there are no conflict of interests. Conceptualisation, investigation, writing-original draft preparation, software, formal analysis: Neda Yaghoubi. Writing-review and editing: Masoud Youssefi. Data curation: Farahzad Jabbari Azad. Methodology, data curation, investigation, and validation: Faramarz Farzad. Data curation: Zahra Yavari. Project administration, funding, supervision: Farnaz Zahedi Avval. The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request. Farnaz Zahedi Avval http://orcid.org/0000-0001-8915-3596 Viral and host factors related to the clinical outcome of COVID-19 COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice Factors associated with COVID-19-related death using OpenSAFELY Sex differences in immune responses that underlie COVID-19 disease outcomes Global absence and targeting of protective immune states in severe COVID-19 Genetic mechanisms of critical illness in COVID-19 Immune-boosting, antioxidant and anti-inflammatory food supplements targeting pathogenesis of COVID-19 SARS-CoV-2 and other respiratory viruses: what does oxidative stress have to do with It COVID-19 infection and oxidative stress: an under-explored approach for prevention and treatment SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and antiinflammatory activity of 4-octyl-itaconate and dimethyl fumarate Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-CoV) infection Oxidative stress and inflammation in COVID-19-associated sepsis: the potential role of anti-oxidant therapy in avoiding disease progression Extracorporeal membrane oxygenation (ECMO) in critically ill patients with coronavirus disease 2019 (COVID-19) pneumonia and acute respiratory distress syndrome (ARDS) Devilishly radical NETwork in COVID-19: oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis Imbalanced host response to SARS-CoV-2 drives development of COVID-19 Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages Clinical and immunological features of severe and moderate coronavirus disease 2019 Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients Spatial oxidation of L-plastin downmodulates actin-based functions of tumor cells Differences in serum markers of oxidative stress in well controlled and poorly controlled asthma in Sri Lankan children: a pilot study Antioxidant strategies and respiratory disease of the preterm newborn: an update First line defence antioxidantssuperoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): their fundamental role in the entire antioxidant defence grid Superoxide dismutase and catalase activity in naturally derived commercial surfactants Covid-19 accelerates endothelial dysfunction and nitric oxide deficiency. Microb Infect COVID-19 human challenge studies: ethical issues Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebocontrolled, phase 1/2 clinical trial Arterial oxygen saturation and other clinical predictors of survival in patients with Covid-19: a review of cases in a tertiary care hospital in Nigeria COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. a narrative review COVID-19 and multiorgan failure: a narrative review on potential mechanisms Prevalence and predictive value of hypocalcemia in severe COVID-19 patients The oxygen paradox, oxidative stress, and ageing Sex differences in the response to oxidative and proteolytic stress Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis Novel approaches for diagnosing and management of cardiovascular disorders mediated by oxidative stress